EW

Edwards Lifesci
NYSE

Real-time Quotes | Nasdaq Last Sale

81.72
-0.16
-0.20%
Pre Market: 82.00 +0.28 +0.34% 08:20 03/08 EST
OPEN
82.29
PREV CLOSE
81.88
HIGH
82.49
LOW
78.86
VOLUME
20
TURNOVER
--
52 WEEK HIGH
92.08
52 WEEK LOW
51.51
MARKET CAP
51.04B
P/E (TTM)
63.32
1D
5D
1M
3M
1Y
5Y
How to Identify the Opportunity and Potential Pitfalls in Edwards Lifesciences $EW
Mar 07, 2021 (Stock Traders Daily via COMTEX) -- This Edwards Lifesciences (NYSE: EW) report helps investors and traders identify both opportunity, and...
Stock Traders Daily · 17h ago
Global Central Venous Catheters Market 2020 Key Players, Comprehensive Research, SWOT Analysis and Forecast by 2025
CDN Newswire · 17h ago
At CAGR of 6.6%, Vascular Access Device Market Top Key Players, Industry Share, Size, Trends and Forecast to 2025
AmericaNewsHour · 18h ago
Global Nitinol-based Medical Device Market 2020 Sales Channels, Technology and Production Analysis, Business Growth by 2025
Mar 07, 2021 (CDN Newswire via Comtex) -- As per a new research report titled Global Nitinol-based Medical Device Market 2020 by Manufacturers, Regions, Type...
CDN Newswire · 22h ago
Global Sutureless Aortic Valve market Size, Share, Value, and Competitive Landscape 2026
Heraldkeepers · 1d ago
Edwards Lifesciences Corp. stock falls Friday, underperforms market
Shares of Edwards Lifesciences Corp. slipped 0.20% to $81.72 Friday, on what proved to be an all-around favorable trading session for the stock market, with...
marketwatch.com · 2d ago
Vascular Access Device Market Potential Growth, Share, Demand and Analysis of Key Players, Research Forecasts To 2027
Mar 05, 2021 (Market Insight Reports) -- Selbyville, Delaware, This Global Vascular Access Device Market report studies the industry based on one or more...
Market Insight Reports · 2d ago
Japan Minimally Invasive Surgical Instruments Market will experience a noticeable growth during the forecast period 2019-2025: Orion Market Reports
Mar 05, 2021 (Market Insight Reports) -- Japan minimally invasive surgical (MIS) instruments market is expected to grow at a CAGR of around 8.2% during the...
Market Insight Reports · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of EW. Analyze the recent business situations of Edwards Lifesci through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 24 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average EW stock price target is 94.25 with a high estimate of 111.00 and a low estimate of 71.00.
EPS
Institutional Holdings
Institutions: 1.53K
Institutional Holdings: 532.12M
% Owned: 85.21%
Shares Outstanding: 624.52M
TypeInstitutionsShares
Increased
391
20.44M
New
219
3.05M
Decreased
385
26.85M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
+1.35%
Healthcare Equipment & Supplies
+2.13%
Key Executives
Chairman/Director/Chief Executive Officer
Michael Mussallem
Chief Financial Officer/Vice President
Scott Ullem
Corporate Executive
Jean-Luc Lemercier
Vice President
Donald Bobo
Vice President
Daveen Chopra
Vice President
Catherine Szyman
Vice President
Huimin Wang
Vice President
Larry Wood
Lead Director/Independent Director
Martha Marsh
Director
Paul LaViolette
Director
Ramona Sequeira
Independent Director
Leslie Heisz
Independent Director
Kieran Gallahue
Independent Director
William Link
Independent Director
Steven Loranger
Independent Director
Heisz Stone
Independent Director
Nicholas Valeriani
No Data
About EW
Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products are categorized into three areas: Transcatheter Heart Valve Therapy, Surgical Heart Valve Therapy and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. It is developing products, such as the Edwards SAPIEN 3 Ultra System and Edwards SAPIEN XT transcatheter heart valve, among others. Its Transcatheter Heart Valve Therapy and Surgical Heart Valve Therapy products are manufactured in the United States, Singapore and Switzerland. Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.

Webull offers kinds of Edwards Lifesciences Corp stock information, including NYSE:EW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading EW stock methods without spending real money on the virtual paper trading platform.